358.50p-6.50 (-1.78%)22 Feb 2024, 17:05
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Maxcyte INC Market & Company News

31.01.2024 07:00MXCTDirector/PDMR ShareholdingRNS
30.01.2024 14:29MXCTHolding(s) in CompanyRNS
30.01.2024 13:58MXCTIN BRIEF: MaxCyte signs licencing deal with cell therapy company WugenAlliance
30.01.2024 13:05MXCTSigning of Strategic Platform LicenseRNS
29.01.2024 17:56MXCTIN BRIEF: MaxCyte chief scientific officer leaves firmAlliance
29.01.2024 16:52MXCTTR-1: Notification of major holdingsRNS
29.01.2024 07:00MXCTFiling of Form 8-KRNS
23.01.2024 18:39MXCT, GSCU, SVMLTRADING UPDATES: Esken's Southend Airport faces further allegationsAlliance
23.01.2024 13:05MXCTSigning of Strategic Platform LicenseRNS
09.01.2024 12:18MXCTMaxCyte's strategic platform licences redeem otherwise modest resultsAlliance
09.01.2024 07:00MXCTPreliminary Unaudited Q4 and FY 2023 ResultsRNS
05.01.2024 07:00MXCTGrant of Options and PDMR DealingRNS
03.01.2024 14:04MXCTMaxCyte teams with Singapore-based Lion to support TCR-T cell workAlliance
03.01.2024 13:05MXCTSigning of Strategic Platform LicenseRNS
02.01.2024 09:23MXCTTotal Voting RightsRNS
02.01.2024 07:00MXCTConfirmation of Board changeRNS
29.12.2023 07:00MXCTExercise of options and PDMR dealingRNS
12.12.2023 15:56MXCT, TM1, ALLTRADING UPDATES: Technology Minerals identifies lithium at KnockeenAlliance
12.12.2023 07:00MXCTCEO Transition and Revenue Guidance UpdateRNS
07.12.2023 09:50MXCTExercise of options and PDMR dealingRNS
04.12.2023 07:00MXCTExercise of options and PDMR dealingRNS
01.12.2023 17:43MXCTTotal Voting RightsRNS
30.11.2023 07:00MXCTExercise of options and PDMR dealingRNS
17.11.2023 07:00MXCTExercise of options and PDMR dealingRNS
16.11.2023 13:05MXCTMaxCyte Joins the Alliance for mRNA MedicinesReach
09.11.2023 14:14VOD, ZEG, DSWEARNINGS AND TRADING: Chapel Down hopes to make splash on AIMAlliance
09.11.2023 07:01MXCTFiling of Form 10-QRNS
09.11.2023 07:00MXCTThird Quarter ResultsRNS
07.11.2023 07:00MXCTParticipation in Upcoming Investor ConferencesRNS
01.11.2023 15:44TMO, SNWS, STBUK earnings, trading statements calendar - next 7 daysAlliance
01.11.2023 13:12MXCTTotal Voting RightsRNS
05.10.2023 10:16TAVI, HE1, MXCTAIM WINNERS & LOSERS: SDX Energy receives gas prepayment from CiticAlliance
05.10.2023 10:08MXCTMaxCyte shares fall as warns of sharp revenue drop, citing volatilityAlliance
02.10.2023 16:03MXCTTotal Voting RightsRNS
13.09.2023 14:28MXCTTR-1: Notification of major holdingsRNS
12.09.2023 13:21MXCTTR-1: Notification of major holdingsRNS
06.09.2023 13:05MXCTAppointment of Executive VP of BioprocessingReach
05.09.2023 16:17MXCTTR-1: Notification of major holdingsRNS
05.09.2023 13:05MXCTBaird Global Healthcare Conference ParticipationRNS
04.09.2023 13:32MXCTTR-1: Notification of major holdingsRNS
04.09.2023 07:00MXCTTotal Voting RightsRNS
01.09.2023 09:01MXCTExercise of options and PDMR dealingRNS
18.08.2023 17:25MXCTTR-1RNS
17.08.2023 16:27MXCTTR-1: Notification of major holdingsRNS
17.08.2023 07:00MXCTTR-1: Notification of Major HoldingsRNS
10.08.2023 10:22MXCTMaxCyte shares fall as revenue plummets in first half, loss widensAlliance
10.08.2023 07:25MXCTFiling of Form 10-QRNS
10.08.2023 07:00MXCTSecond Quarter and Half-Year ResultsRNS
08.08.2023 15:15MXCTTR-1: Notification of major holdingsRNS
07.08.2023 17:01MXCTTotal Voting Rights and Block Listing ReturnRNS
02.08.2023 15:46EGY, TUI, TCAPUK earnings, trading statements calendar - next 7 daysAlliance
01.08.2023 14:26PALM, CNC, MXCTTRADING UPDATES: MaxCyte strikes deal; Barkby sells Workshop Alliance
01.08.2023 13:05MXCTStrategic Platform License with Prime MedicineRNS
31.07.2023 17:26MXCTExercise of options and PDMR dealingRNS
26.07.2023 14:31MXCTTR-1: Notification of major holdingsRNS
24.07.2023 17:08MXCTTR-1: Notification of major holdingsRNS
24.07.2023 17:06MXCTTR-1: Notification of major holdingsRNS
13.07.2023 13:05MXCTNotice of Second Quarter 2023 Financial ResultsRNS
11.07.2023 07:00MXCTTR-1: Notification of major holdingsRNS
10.07.2023 14:05MXCTMaxCyte inks deal with Vittoria Therapeutics for cellular therapiesAlliance
10.07.2023 13:05MXCTSigning of Strategic Platform LicenseRNS
10.07.2023 07:00MXCTTR-1: Notification of major holdingsRNS
07.07.2023 09:23MXCTTotal Voting RightsRNS
06.07.2023 16:41MXCTTR-1: Notification of major holdingsRNS
06.07.2023 13:58MXCTMaxCyte inks strategic platform license with Lyell ImmunopharmaAlliance
06.07.2023 13:05MXCTSigning of Strategic Platform LicenseRNS
29.06.2023 15:19MXCTTR-1: Notification of major holdingsRNS
29.06.2023 07:00MXCTTR-1: Notification of major holdingsRNS
29.06.2023 07:00MXCTExercise of options and PDMR dealingRNS
23.06.2023 15:46MXCTGrant of OptionsRNS
23.06.2023 07:17MXCTResult of AGMRNS
23.06.2023 07:00MXCTResult of AGMRNS
21.06.2023 10:10MXCTPublication of Annual ReportRNS
16.06.2023 12:32MXCTExercise of options and PDMR dealingRNS
02.06.2023 07:00MXCTUpcoming Investor ConferencesRNS
Showing 1 to 75 of 222